| Financial Year |
March 31 2023 |
| Monetary Funds |
379,410,077.49 |
| Held-for-trading Financial Assets |
3,526,420,692.51 |
| Notes Receivable |
25,195,091.57 |
| Accounts Receivable |
1,331,912,123.26 |
| Advances to Suppliers |
36,106,610.60 |
| Other Receivables |
43,872,959.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
518,756,825.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,716,991.02 |
| Total Current Assets |
5,975,210,087.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
260,739,764.14 |
| Under-construction Projects |
116,506,545.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
108,967,517.08 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,923,436.89 |
| Deferred Income Tax Assets |
17,472,595.06 |
| Other Non-Current Assets |
57,631,897.20 |
| Sub-Total of Non-Current Assets |
589,910,273.63 |
| Total Assets |
6,565,120,361.41 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
255,998,348.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
142,075,085.94 |
| Taxes Payable |
23,954,765.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
62,799,401.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,198,578.71 |
| Other Current Liabilities |
1,666,758.46 |
| Sub-Total of Current Liabilities |
942,083,857.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
71,657,617.38 |
| Deferred Income Tax Liabilities |
14,184,567.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
94,004,636.03 |
| Total Liabilities |
1,036,088,493.95 |
| Paid-In Capital(Or Share Stock) |
330,000,000.00 |
| Capital Surplus |
3,879,605,343.59 |
| Surplus Reserve |
135,882,303.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,183,544,220.49 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,529,031,867.46 |
| Owner's Equity（Stockholder's Equity） |
5,529,031,867.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,565,120,361.41 |
